BEXAROTENE
| Brand name | BEXAROTENE |
|---|---|
| Active ingredient | BEXAROTENE |
| Strength | 1% |
| Dosage form | GEL |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | April 2022 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.